Impact of antidiabetic treatment with dipeptidyl peptidase-4 inhibitors on the risk of cardiac arrhythmias among patients with type 2 diabetes mellitus

被引：0
|
作者：
Boulmpou, A. [1 ]
Patoulias, D. [2 ]
Teperikidis, E. [1 ]
Tsavousoglou, C. [1 ]
Vergopoulos, S. [1 ]
Toumpourleka, M. [1 ]
Doumas, M. [2 ]
Fragakis, N. [1 ]
Vassilikos, V. [1 ]
Papadopoulos, C. E. [1 ]
机构：
[1] Hippokrat Gen Hosp Thessaloniki, Dept Cardiol 3, Thessaloniki, Greece
[2] Hippokrat Gen Hosp Thessaloniki, Propedeut Dept Internal Med 2, Thessaloniki, Greece
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2955 / 2955
页数：1
相关论文
共 50 条
  • [31] Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus
    Jie Meng
    Rui Yan
    Chen Zhang
    Xueyan Bai
    Xingsheng Yang
    Yu Yang
    Tao Feng
    Xin Liu
    Lipids in Health and Disease, 22
  • [32] Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
    Deacon, C. F.
    DIABETES OBESITY & METABOLISM, 2011, 13 (01): : 7 - 18
  • [33] Dipeptidyl peptidase-4 inhibitors in triple oral therapy regimens in patients with type 2 diabetes mellitus
    Barnett, Anthony H.
    Charbonnel, Bernard
    Moses, Robert G.
    Kalra, Sanjay
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (10) : 1919 - 1931
  • [34] Treatment of Elderly Patients With Type 2 Diabetes Mellitus: A Systematic Review of the Benefits and Risks of Dipeptidyl Peptidase-4 Inhibitors
    Schwartz, Sherwyn L.
    AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2010, 8 (05): : 405 - 418
  • [35] Effects of dipeptidyl peptidase-4 inhibitors on cardiac and endothelial function in type 2 diabetes mellitus: A pilot study
    Leung, Melissa
    Leung, Dominic Y.
    Wong, Vincent W.
    DIABETES & VASCULAR DISEASE RESEARCH, 2016, 13 (03): : 236 - 243
  • [36] Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes
    Koska, Juraj
    Sands, Michelle
    Burciu, Camelia
    Reaven, Peter
    DIABETES & VASCULAR DISEASE RESEARCH, 2015, 12 (03): : 154 - 163
  • [37] Managing Hyperglycemia in Patients With Type 2 Diabetes Mellitus: Rationale for the Use of Dipeptidyl Peptidase-4 Inhibitors in Combination With Other Oral Antidiabetic Drugs
    Freeman, Jeffrey S.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2010, 110 (09): : 528 - 537
  • [38] Meta-Analysis of Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Risk in Type 2 Diabetes Mellitus
    Patil, Harshal R.
    Al Badarin, Firas J.
    Al Shami, Hamza A.
    Bhatti, Salman K.
    Lavie, Carl J.
    Bell, David S. H.
    O'Keefe, James H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (06): : 826 - 833
  • [39] Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus
    Wei, Xin
    Bai, Yu
    Wang, Zhuo
    Zheng, Xiaohong
    Jin, Zening
    Liu, Xin
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [40] Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review
    Ruan, Zhen
    Zou, Huimin
    Lei, Qing
    Ung, Carolina Oi Lam
    Shi, Honghao
    Hu, Hao
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (04) : 555 - 574
12345